Metabolomics reveals intratumor heterogeneity - Implications for precision medicine

EBioMedicine. 2017 May:19:4-5. doi: 10.1016/j.ebiom.2017.04.030. Epub 2017 Apr 24.

Authors

Xiaojing Liu¹, Jason W Locasale²

Affiliations

¹ Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina, 27710, USA.
² Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina, 27710, USA. Electronic address: Jason.Locasale@duke.edu.

No abstract available

Publication types

Comment

MeSH terms

Breast Neoplasms
Humans
Metabolomics*
Precision Medicine*

Grants and funding

R00 CA168997/CA/NCI NIH HHS/United States